239,019 Shares in Merit Medical Systems, Inc. (MMSI) Acquired by Emerald Mutual Fund Advisers Trust

Emerald Mutual Fund Advisers Trust acquired a new stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 239,019 shares of the medical instruments supplier’s stock, valued at approximately $10,122,000. Emerald Mutual Fund Advisers Trust owned approximately 0.48% of Merit Medical Systems at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. SG Americas Securities LLC acquired a new stake in shares of Merit Medical Systems in the 1st quarter valued at $134,000. LS Investment Advisors LLC raised its stake in Merit Medical Systems by 8.1% during the 2nd quarter. LS Investment Advisors LLC now owns 3,694 shares of the medical instruments supplier’s stock worth $141,000 after acquiring an additional 277 shares in the last quarter. Advisors Asset Management Inc. raised its stake in Merit Medical Systems by 28.2% during the 2nd quarter. Advisors Asset Management Inc. now owns 3,723 shares of the medical instruments supplier’s stock worth $142,000 after acquiring an additional 820 shares in the last quarter. Ameritas Investment Partners Inc. raised its stake in Merit Medical Systems by 20.9% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,272 shares of the medical instruments supplier’s stock worth $163,000 after acquiring an additional 738 shares in the last quarter. Finally, Riverhead Capital Management LLC raised its stake in Merit Medical Systems by 67.7% during the 2nd quarter. Riverhead Capital Management LLC now owns 5,198 shares of the medical instruments supplier’s stock worth $198,000 after acquiring an additional 2,098 shares in the last quarter. Institutional investors and hedge funds own 89.11% of the company’s stock.

In other Merit Medical Systems news, Director Kent W. Stanger sold 1,930 shares of Merit Medical Systems stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $42.02, for a total transaction of $81,098.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 5.00% of the stock is currently owned by insiders.

TRADEMARK VIOLATION NOTICE: “239,019 Shares in Merit Medical Systems, Inc. (MMSI) Acquired by Emerald Mutual Fund Advisers Trust” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark laws. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2017/11/12/239019-shares-in-merit-medical-systems-inc-mmsi-acquired-by-emerald-mutual-fund-advisers-trust.html.

Shares of Merit Medical Systems, Inc. (NASDAQ MMSI) traded down $0.65 during trading hours on Friday, hitting $36.80. 288,300 shares of the stock traded hands, compared to its average volume of 494,582. The stock has a market capitalization of $1,847.32, a P/E ratio of 28.98, a price-to-earnings-growth ratio of 2.49 and a beta of 1.20. Merit Medical Systems, Inc. has a 1-year low of $22.10 and a 1-year high of $45.50. The company has a current ratio of 2.78, a quick ratio of 1.43 and a debt-to-equity ratio of 0.39.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings data on Wednesday, October 25th. The medical instruments supplier reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.30 by $0.02. The firm had revenue of $179.30 million for the quarter, compared to the consensus estimate of $181.28 million. Merit Medical Systems had a net margin of 4.06% and a return on equity of 9.86%. The firm’s revenue was up 14.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.26 earnings per share. sell-side analysts forecast that Merit Medical Systems, Inc. will post 1.27 earnings per share for the current fiscal year.

MMSI has been the topic of several research analyst reports. Zacks Investment Research upgraded shares of Merit Medical Systems from a “hold” rating to a “buy” rating and set a $43.00 price target on the stock in a research note on Saturday, October 28th. Citigroup Inc. lowered shares of Merit Medical Systems from a “strong-buy” rating to an “outperform” rating and set a $44.00 price target on the stock. in a research note on Monday, August 28th. They noted that the move was a valuation call. Canaccord Genuity lifted their price target on shares of Merit Medical Systems from $45.00 to $47.50 and gave the stock a “buy” rating in a research note on Thursday, October 26th. Raymond James Financial, Inc. reiterated an “outperform” rating and set a $44.00 price target on shares of Merit Medical Systems in a research note on Monday, August 28th. Finally, UBS AG downgraded shares of Merit Medical Systems from a “strong-buy” rating to an “outperform” rating in a research report on Monday, August 28th. One analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $41.65.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply